<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03153397</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00081414</org_study_id>
    <nct_id>NCT03153397</nct_id>
  </id_info>
  <brief_title>Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome in Neurological Injury Trauma Patients (PreFEED Microbiome Trial)</brief_title>
  <official_title>Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome in Neurological Injury Trauma Patients (PreFEED Microbiome Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study plans to learn more about the impact of enteral nutrition on bacteria in&#xD;
      critically ill trauma patients with brain injury. Specifically, it seeks to understand the&#xD;
      effect that a prebiotic containing enteral feeding formula (Nutraflora scFOS in Vital AF) has&#xD;
      on the gut, oral, and skin bacteria. A prebiotic is a special form of dietary fiber that acts&#xD;
      as a fertilizer for good bacteria. The prebiotic Nutraflora scFOS has been cleared by the&#xD;
      U.S. Food and Drug Administration and is not considered investigational as used in this&#xD;
      study. Enteral feeding is a way to give nutrition to critically ill people who are unable to&#xD;
      eat.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 23, 2017</start_date>
  <completion_date type="Actual">May 31, 2021</completion_date>
  <primary_completion_date type="Actual">February 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in microbiome</measure>
    <time_frame>Baseline (within 48 hours of ICU admission), up to 10 days</time_frame>
    <description>Stool samples</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall microbiome composition sampling gut</measure>
    <time_frame>Baseline (within 48 hours of ICU admission), up to 10 days</time_frame>
    <description>Stool samples</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in microbiome longitudinally</measure>
    <time_frame>Baseline at Day 2, 4, 6, 8 and 10</time_frame>
    <description>Tongue swab microbiome longitudinally</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in the microbiome on delivery of initial clinical outcomes in trauma patients</measure>
    <time_frame>Baseline (within 48 hours of ICU admission), up to 10 days</time_frame>
    <description>Stool samples</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Record length of mechanical ventilation</measure>
    <time_frame>Up to 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU</measure>
    <time_frame>Up to 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Up to 60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Up to 60 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Enteral Nutrition</condition>
  <condition>Brain Injuries, Traumatic</condition>
  <condition>ICU Admission</condition>
  <arm_group>
    <arm_group_label>Nutraflora scFOS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>prebiotic fiber-containing formula (Nutraflora scFOS)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Osmolite</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>non-prebiotic fiber containing formula (Osmolite)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutraflora scFOS</intervention_name>
    <description>prebiotic fiber (Nutraflora scFOS via Vital AF)</description>
    <arm_group_label>Nutraflora scFOS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Osmolite</intervention_name>
    <description>non-prebiotic fiber containing formula (Osmolite)</description>
    <arm_group_label>Osmolite</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adult major neurological injury trauma patients between 18-70 years of age who have&#xD;
             been admitted directly to trauma ICU following major trauma&#xD;
&#xD;
          2. Expected length of mechanical ventilation &gt; 48 hours (as judged by admitting&#xD;
             clinician)&#xD;
&#xD;
          3. Expected length of ICU stay &gt; 3 days (as judged by admitting clinician)&#xD;
&#xD;
          4. Expected to survive &gt; 48 hours (as judged by admitting clinician)&#xD;
&#xD;
          5. Requiring enteral nutrition at any time in Intensive Care Unit (ICU) stay&#xD;
&#xD;
          6. Chronic illnesses must be under control (as determined by the Principal Investigator).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Previous hospitalization within one month prior to ICU admission (no hospital floor&#xD;
             transfers to eliminate confounding effect of previous hospital therapy)&#xD;
&#xD;
          2. Use of prebiotic fiber containing enteral or oral formula or probiotic preparations&#xD;
             within one week&#xD;
&#xD;
          3. Received antibiotics within the previous month&#xD;
&#xD;
          4. On steroids or immunosuppressants at time of admission&#xD;
&#xD;
          5. All transplant patients&#xD;
&#xD;
          6. Chronic inflammatory disease that requires steroids or other biologic therapy&#xD;
             intervention (e.g.: RA, IBD that requires steroids or Humira)&#xD;
&#xD;
          7. Undergoing active chemotherapy/radiation treatment&#xD;
&#xD;
          8. Renal failure requiring dialysis&#xD;
&#xD;
          9. Liver cirrhosis class C&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Wischmeyer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 11, 2017</study_first_submitted>
  <study_first_submitted_qc>May 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2017</study_first_posted>
  <last_update_submitted>June 2, 2021</last_update_submitted>
  <last_update_submitted_qc>June 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>trauma</keyword>
  <keyword>brain</keyword>
  <keyword>neurological</keyword>
  <keyword>injury</keyword>
  <keyword>enteral</keyword>
  <keyword>tube</keyword>
  <keyword>feeding</keyword>
  <keyword>nutrition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Trauma, Nervous System</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

